Abstract
Fecal swabs obtained from 1,300 healthy lambs in 93 flocks in Spain in 1997 were examined for Shiga toxin-producing Escherichia coli (STEC). STEC O157:H7 strains were isolated from 5 (0.4%) animals in 4 flocks, and non-O157 STEC strains were isolated from 462 (36%) lambs in 63 flocks. A total of 384 ovine STEC strains were characterized in this study. PCR showed that 213 (55%) strains carried the stx1 gene, 10 (3%) possessed the stx2 gene, and 161 (42%) carried both the stx1 and the stx2 genes. Enterohemolysin (ehxA) and intimin (eae) virulence genes were detected in 106 (28%) and 23 (6%) of the STEC strains, respectively. The STEC strains belonged to 35 O serogroups and 64 O:H serotypes (including 18 new serotypes). However, 72% were of 1 of the following 12 serotypes: O5:H−, O6:H10, O91:H−, O117:H−, O128:H−, O128:H2, O136:H20, O146:H8, O146:H21, O156:H−, O166:H28, and ONT:H21 (where NT is nontypeable). Although the 384 STEC strains belonged to 95 different seropathotypes (associations between serotypes and virulence genes), 49% of strains belonged to only 11. O91:H− stx1 stx2 (54 strains) was the most common seropathotype, followed by O128:H− stx1 stx2 (33 strains) and O6:H10 stx1 (25 strains). Three strains of serotypes O26:H11, O156:H11, and OX177:H11 had intimin type β1; 5 strains of serotype O157:H7 possessed intimin type γ1; and 15 strains of serotypes O49:H−, O52:H12, O156:H− (12 strains), and O156:H25 had the new intimin, intimin type ζ. The majority (82%) of ovine STEC strains belonged to serotypes previously found to be associated with human STEC strains, and 51% belonged to serotypes associated with STEC strains isolated from patients with hemolytic-uremic syndrome. Thus, this study confirms that healthy sheep are a major reservoir of STEC strains pathogenic for humans.
Shiga toxin-producing Escherichia coli (STEC), also called verotoxin-producing E. coli (VTEC), has emerged as a pathogen that can cause food poisoning and severe and potentially fatal illnesses. It is a major cause of gastroenteritis that may be complicated by hemorrhagic colitis (HC) or the hemolytic-uremic syndrome (HUS), which is the main cause of acute renal failure in children. Since its identification as a pathogen in 1982, STEC O157:H7 has been the cause of a series of outbreaks, especially in Canada, Japan, the United Kingdom, and the United States (19, 23, 27). Domestic ruminants, especially cattle, sheep, and goats, have been implicated as the principal reservoir of STEC strains that cause human infections, although other domestic animals, including pigs, poultry, cats, and dogs, can also harbor these bacteria. Transmission occurs through consumption of undercooked meat, unpasteurized dairy products, and vegetables or water contaminated by the feces of carriers, because STEC strains are found as part of the normal intestinal flora of the animals. Person-to-person transmission has also been documented (6, 9, 11, 12, 34).
STEC strains elaborate two potent phage-encoded cytotoxins called Shiga toxins (Stx1 and Stx2) or verotoxins (VT1 and VT2) (19, 27). In addition to toxin production, another virulence-associated factor expressed by STEC is a protein called intimin, which is responsible for the intimate attachment of STEC to intestinal epithelial cells, causing attaching-and-effacing lesions in the intestinal mucosa (17). Intimin is encoded by the chromosomal gene eae, which is part of a pathogenicity island termed the locus for enterocyte effacement. Intimin type-specific PCR assays identified eight variants of the eae gene that encode eight different intimin types (types α, β1, β2, γ1, γ2, δ, ɛ, and ζ) (1, 23, 24, 30, 31, 33). Severe diarrhea (especially HC) and HUS are closely associated with STEC types carrying the eae gene for intimin. A factor that may also affect the virulence of STEC strains is the enterohemolysin (Ehly), also called enterohemorrhagic E. coli hemolysin (EHEC-HlyA), which is encoded by the ehxA gene (28).
STEC strains that cause human infections belong to a large number of O:H serotypes (a total of 435 serotypes are listed on the authors' website [http://www.lugo.usc/ecoli]; a review of the world literature by K. A. Bettelheim recording well over 1,000 reports of isolation of non-O157 STEC strains is also available [http://www.sciencenet.com.au]) (6, 23). Most outbreaks and sporadic cases of HC and HUS have been attributed to strains of enterohemorrhagic serotype O157:H7 (6, 10, 19, 23). However, as STEC non-O157 strains are more prevalent in animals and as contaminants in foods, humans are probably more exposed to these strains. Infections with some non-O157 STEC types, such as O26:H11 or O26:H−, O91:H21 or O91:H−, O103:H2, O111:H−, O113:H21, O117:H7, O118:H16, O121:H19, O128:H2 or O128:H−, O145:H28 or O145:H−, and O146:H21, are frequently associated with severe illness in humans, but the roles of other non-O157 STEC types in human disease require further examination (4, 6, 10, 23).
Recently, STEC O157:H7 strains have been detected in sheep and goat feces or at slaughter, showing that small ruminants may also represent a source of contamination for humans. Transmission of STEC O157:H7 and other STEC serotypes to humans by raw goat milk or homemade cheese made from raw milk has been demonstrated (5, 6). However, small ruminants have been subjected to fewer surveys compared with the number of surveys done with cattle. The majority of existing studies have been performed with comparatively small numbers of sheep, have focused intensively on a single flock, or have examined small ruminants only for the presence of serotype O157:H7 (11, 12, 14, 16, 18, 32). Thus, the aim of this study was to establish the serotypes and the virulence genes of STEC strains isolated from sheep in Spain to determine whether sheep represent a source of STEC strains pathogenic for humans.
MATERIALS AND METHODS
Specimen collection and E. coli strains.
A total of 1,300 healthy lambs from 93 flocks in Extremadura, Spain, were sampled between June and October 1997. A single fecal swab was obtained from each lamb up to 2 month of age. The swabs were placed in transport medium and taken to a laboratory for immediate processing. They were plated on MacConkey agar and on cefixime-tellurite-sorbitol MacConkey medium, and 10 suspect E. coli colonies (lactose positive, lactose negative, or sorbitol negative) were chosen from each sample, identified, and examined for Shiga toxin (verotoxin) production. Identification of E. coli was based on standard biochemical tests. Only one colony from animals for which all original isolates were identical with respect to the toxic genotype and serotype was selected as a test strain. When one lamb yielded colonies with different seropathotypes, one colony of each seropathotype was selected. Reference E. coli strains used as controls were 933 (O157:H7 stx1 stx2 eae-γ1 ehxA), EPEC-8 (O55:H6 eae-α), EPEC-4 (O26:H− eae-β1), EPEC-359 (O119:H6 eae-β2), VTB-308 (O111:H− stx1 eae-γ2), EPEC-9 (O86:H34 eae-δ), VTB-286 (O103:H2 stx1 eae-ɛ), VTO-50 (O156:H− stx1 eae-ζ), and K-12 185 (negative for the stx1, stx2, eae, and ehxA genes). The strains were stored at room temperature in nutrient broth with 0.75% agar.
Production and detection of Shiga toxins (verotoxins) in Vero and HeLa cells.
For production of Shiga toxins, one loopful of each isolated colony was inoculated in 50-ml Erlenmeyer flasks containing 5 ml of tryptone soy broth (pH 7.5) with mitomycin C and incubated for 20 h at 37°C (shaken at 200 rpm) and then centrifuged (6,000 × g) for 30 min at 4°C. The Vero and HeLa cell culture assays were performed with nearly confluent cell monolayers grown in plates with 24 wells. At the time of assay, the growth medium (RPMI with polymyxin B sulfate) was changed (0.5 ml per well), and 75 μl of undiluted culture supernatant was added. The cells were incubated at 37°C in a 5% CO2 atmosphere, and after 24 and 48 h of incubation the morphological changes in the cells were observed with a phase-contrast inverted microscope (7, 8).
Detection of virulence genes by PCR.
Bacteria were harvested from tryptone soy agar, suspended in 250 μl of sterile water, incubated at 100°C for 5 min to release the DNA, and centrifuged. The supernatant was used in the PCR as described below. The base sequences and the predicted sizes of the amplified products for the specific oligonucleotide primers used in this study are shown in Table 1. We designed the majority of oligonucleotide primers according to the nucleotide sequences of the virulence genes. Multiplex PCR was used only for detection of the stx1 and stx2 genes. The DNA of isolates positive for the eae gene with primers EAE-1 and EAE-2 was later analyzed with all different variant primers. Amplification of bacterial DNA was performed by using 30-μl volumes containing 7 μl of the prepared sample supernatant; the oligonucleotide primers (see Table 1); 0.2 mM (each) dATP, dGTP, dCTP, and dTTP; 10 mM Tris-HCl (pH 8.8); 1.5 mM MgCl2; 50 mM KCl, and 1 U of Biotaq DNA polymerase (Bioline, London, United Kingdom). The conditions for the PCR, which was performed with a thermal cycler (model PCR express; Hybaid, Teddington, United Kingdom), were 94°C for 2 min for initial denaturation of the DNA within the sample, followed by 35 cycles of 94°C for 1 min (denaturation), 55 to 63°C (Table 1) for 1 min (primer annealing), and 72°C for 1 min (DNA synthesis). The amplified products were visualized by standard submarine gel electrophoresis by using 10 μl of the final reaction mixture on a 2% agarose gel in TBE buffer (89 mM Tris, 89 mM boric acid, 2.5 mM EDTA). The samples were electrophoresed for 20 to 40 min at 130 V. Amplified DNA fragments of specific sizes were located by UV fluorescence after staining with ethidium bromide. Molecular size markers (HaeIII digest of φX174 DNA; Promega, Madison, Wis.) were included in each gel.
TABLE 1.
Primer sequences and predicted lengths of PCR amplification products
Gene | Primer | Oligonucleotide sequence (5′-3′) | Fragment size (bp) | PCR conditionsa | Primer coordinates | GenBank accession no.b | Reference or source |
---|---|---|---|---|---|---|---|
stx1 | VT1-A | CGCTGAATGTCATTCGCTCTGC | 302 | 90 ng, 55°C | 113-134 | M17358 | This study |
VT1-B | CGTGGTATAGCTACTGTCACC | 394-414 | |||||
stx2 | VT2-A | CTTCGGTATCCTATTCCCGG | 516 | 60 ng, 55°C | 50-69 | M59432 | This study |
VT2-B | CTGCTGTGACAGTGACAAAACGC | 543-565 | |||||
ehxA | HlyA1 | GGTGCAGCAGAAAAAGTTGTAG | 1.551 | 90 ng, 60°C | 238-259 | X79839 | 28 |
HlyA4 | TCTCGCCTGATAGTGTTTGGTA | 1767-1788 | |||||
eae | EAE-1 | GAGAATGAAATAGAAGTCGT | 775 | 150 ng, 55°C | 1441-1460 | M58154 | This study |
EAE-2 | GCGGTATCTTTCGCGTAATCGCC | 2193-2215 | |||||
eae-α | EAE-F | ATTACTGAGATTAAGGCTGAT | 751 | 150 ng, 58°C | 1978-1998 | AF022236 | This study |
EAE-A | CACTCTTCGCATCTTGAGCT | 2709-2728 | |||||
eae-β1 | EA-B1-F | CGCCACTTAATGCCAGCG | 724 | 300 ng, 60°C | 1928-1945 | U38618 | This study |
EAE-B1 | GCAGCACCCCATGTTGAAT | 2633-2651 | |||||
eae-β2 | EA-B2-F | CCCGCCACTTAATCGCACGT | 720 | 300 ng, 60°C | 1929-1948 | AF043226 | This study |
EAE-B2 | GCAGCACCCCATGTTGAGATA | 2628-2648 | |||||
eae-γ1 | EAE-F | ATTACTGAGATTAAGGCTGAT | 739 | 150 ng, 58°C | 1978-1998 | S90827 | This study |
EAE-C1 | CTCCAGAACGCTGCTCACT | 2698-2716 | |||||
eae-γ2 | EAE-F | ATTACTGAGATTAAGGCTGAT | 739 | 150 ng, 58°C | 1978-1998 | AF025311 | This study |
EAE-C2 | CTGATATTTTATCAGCTTCA | 2697-2716 | |||||
eae-δ | EAE-F | ATTACTGAGATTAAGGCTGAT | 764 | 150 ng, 58°C | 1978-1998 | U66102 | This study |
EAE-D | CTTGATACACCCGATGGTAAC | 2721-2741 | |||||
eae-ɛ | EAE-F | ATTACTGAGATTAAGGCTGAT | 653 | 150 ng, 60°C | 1978-1998 | AF116899 | This study |
LP5 | AGCTCACTCGTAGATGACGGCAAGCG | 2605-2630 | |||||
eae-ζ | Z1 | GAAGGCAAATGGATCTGA | 258 | 150 ng, 63°C | 2010-2027 | AF449417 | This study |
Z2 | ATAGCAAGTGGGGTGAAG | 2250-2267 |
Amount of oligonucleotide primers, annealing temperature.
The majority of oligonucleotide primers were designed by us according to the nucleotide sequences of the eae genes.
Serotyping.
The determination of the O and H antigens was carried out by the method described by Guinée et al. (15) with all available O (O1 to O181) and H (H1 to H56) antisera. All antisera were obtained and absorbed with the corresponding cross-reacting antigens to remove the nonspecific agglutinins. The O antisera were produced in the Laboratorio de Referencia de E. coli (Lugo, Spain [http://www.lugo.usc.es/ecoli]), and the H antisera were obtained from the Statens Serum Institut (Copenhagen, Denmark).
RESULTS
Prevalence of VTEC in healthy sheep.
Fecal swabs obtained from 1,300 healthy lambs in 93 flocks in Spain in 1997 were examined for STEC strains. We found STEC strains in 63 (68%) of the flocks. STEC O157:H7 strains were isolated from 5 (0.4%) animals in 4 flocks, and non-O157 STEC strains were isolated from 462 (36%) lambs in 63 flocks.
Virulence genes.
A total of 384 ovine STEC strains were characterized in this study. PCR showed that 213 (55%) strains carried the stx1 gene, 10 (3%) possessed the stx2 gene, and 161 (42%) carried both the stx1 and stx2 genes. The ehxA and eae virulence genes were detected in 106 (28%) and 23 (6%) of the STEC strains, respectively.
Serotypes and seropathotypes.
The STEC strains belonged to 35 O serogroups and 64 O:H serotypes. However, 76% of the strains were of 1 of 10 serogroups (O5, O6, O91, O117, O128, O136, O146, O156, O166, and O176), and 72% belonged to only 12 serotypes (O5:H−, O6:H10, O91:H−, O117:H−, O128:H−, O128:H2, O136:H20, O146:H8, O146:H21, O156:H−, O166:H28, and ONT:H21 [where NT is nontypeable]). A total of 18 new O:H serotypes not previously reported for STEC strains were found in this study. The majority (82%) of ovine STEC strains belonged to serotypes previously found to be associated with human STEC strains, and 51% belonged to serotypes previously associated with STEC strains isolated from patients with HUS (Table 2).
TABLE 2.
Seropathotypes (serotypes and virulence genes) of ovine STEC strainsd
Serotype | Total no. of strains tested | stx1 | stx2 | eae | ehxA | Serotype | Total no. of strains tested | stx1 | stx2 | eae | ehxA | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
O4:H−b | 1 | + | + | − | + | |||||||
O4:H−b | 1 | + | − | − | + | |||||||
O4:H10a | 1 | + | − | − | − | |||||||
O5:H−b | 10 | + | + | − | + | |||||||
O5:H−b | 8 | + | − | − | + | |||||||
O5:H−b | 1 | + | − | − | − | |||||||
O5:H28c | 1 | + | − | − | + | |||||||
O6:H−b | 1 | + | − | − | + | |||||||
O6:H−b | 2 | + | − | − | − | |||||||
O6:H2b | 1 | + | − | − | + | |||||||
O6:H10 | 25 | + | − | − | − | |||||||
O6:H12a | 1 | + | − | − | + | |||||||
O6:H28a | 1 | + | − | − | − | |||||||
O8:H9a | 1 | − | + | − | − | |||||||
O9:H−b | 1 | + | + | − | − | |||||||
O15:H−b | 1 | + | − | − | + | |||||||
O26:H11b | 1 | + | − | + (β1) | + | |||||||
O35:H7c | 1 | + | − | − | − | |||||||
O42:H?c | 1 | + | − | − | − | |||||||
O49:H−b | 1 | + | + | + (ζ) | + | |||||||
O52:H12c | 1 | + | − | + (ζ) | + | |||||||
O52:H45c | 3 | + | − | − | − | |||||||
O55:H−b | 1 | + | + | − | − | |||||||
O55:H−b | 1 | + | − | − | − | |||||||
O55:H2c | 2 | + | − | − | − | |||||||
O75:H−b | 1 | + | + | − | − | |||||||
O75:H55c | 1 | + | + | − | + | |||||||
O79:H14a | 2 | + | − | − | − | |||||||
O87:H2c | 1 | + | + | − | − | |||||||
O91:H−b | 6 | + | + | − | + | |||||||
O91:H−b | 54 | + | + | − | − | |||||||
O91:H−b | 3 | + | − | − | − | |||||||
O91:H−b | 1 | − | + | − | − | |||||||
O91:H21b | 1 | + | − | − | − | |||||||
O91:H29c | 1 | + | − | − | − | |||||||
O98:H7c | 1 | + | − | − | − | |||||||
O104:H7a | 9 | + | − | − | − | |||||||
O106:H2c | 1 | + | − | − | − | |||||||
O106:H20c | 1 | + | − | − | − | |||||||
O110:H−a | 7 | + | − | − | − | |||||||
O112:H−b | 7 | + | − | − | − | |||||||
O112:H21a | 1 | + | − | − | − | |||||||
O117:H−a | 16 | + | − | − | − | |||||||
O118:H12b | 1 | + | − | − | − | |||||||
O118:H12b | 1 | − | + | − | − | |||||||
O119:H−a | 1 | + | + | − | − | |||||||
O123:H−a | 1 | + | + | − | + | |||||||
O123:H−a | 2 | + | + | − | − |
Serotypes previously found for human VTEC strains.
Serotypes previously associated with human VTEC strains that caused HUS.
New serotypes not found for VTEC strains in previous studies.
A total of 384 ovine STEC strains were tested.
Although the 384 STEC strains belonged to 95 seropathotypes (associations between serotypes and virulence genes), 49% of strains belonged to only 11. O91:H− stx1 stx2 (54 strains) was the most common seropathotype, followed by O128:H− stx1 stx2 (33 strains) and O6:H10 stx1 (25 strains) (Table 2).
Typing of eae (intimin) genes.
Three strains of serotypes O26:H11, O156:H11, and OX177:H11, respectively, had intimin type β1; 5 strains of serotype O157:H7 possessed intimin type γ1; and 15 strains of serotypes O49:H− (1 strain), O52:H12 (1 strain), O156:H− (12 strains), and O156:H25 (1 strain) had the new intimin, intimin type ζ.
DISCUSSION
We isolated STEC O157:H7 strains from 0.4% of the swab samples from the animals tested in Spain in 1997, whereas we isolated non-O157 VTEC strains from 36% of the samples from lambs. The prevalence rate of STEC O157:H7 in that study was probably underestimated, as immunomagnetic separation was not used. In a subsequent study conducted in Spain in 2000 and 2001, we used immunomagnetic separation, and STEC O157:H7 strains were isolated from 1% of the lambs (unpublished data). The prevalence rates of non-O157 STEC strains were higher in sheep (67%) and goats (56%) than in cattle (21%) in Germany. Among the flocks, the percentage of positive animals varied greatly, from 7 to 84% of the animals in goat flocks and from 55 to 95% of the animals in sheep flocks (2). In Australia, STEC strains were identified in 40% of goats and 56 to 73% of sheep examined in three studies (13, 14, 29). In the United States, Kudva et al. (20, 21) detected STEC strains in 43% of sheep. Four groups have surveyed sheep populations using methods sensitive for STEC O157:H7 strains (11, 16, 18, 20, 21). In the United Kingdom, a survey of 1,000 sheep at a slaughterhouse found the agent in the feces of 22 (2%) animals, a rate lower than that obtained for cattle (16%) at the same site (11). Similarly, in The Netherlands, STEC O157:H7 strains were isolated from 2 (4%) of 52 ewes, 2 (4%) of 49 lambs, 57 (11%) of 540 adult cattle, and 2 (0.5%) of 397 veal calves (16). In Norway, although a sensitive method was used, no STEC O157:H7 strains were isolated from 364 sheep (18). In contrast, Kudva et al. (20, 21) detected STEC O157:H7 strains in a large percentage (31%) of samples from sheep in a flock in the United States. One flock was investigated for STEC O157:H7 strains over a 16-month period, and a variation in occurrence was observed (0 to 31%), with animals being culture positive only in the summer months and not in the spring, autumn, or winter months.
Sheep harbor many serotypes of STEC in their gastrointestinal tracts. Ovine STEC strains belonging to a total of 53 O serogroups and 105 O:H serotypes have been isolated in studies that we have reviewed (6, 23). The complete list of 105 O:H serotypes is available from the authors' website (http://www.lugo.usc/ecoli). The present study is the first, to our knowledge, that documents the verotoxigenicities of E. coli strains of 18 new O:H serotypes (Table 2). Only a small number of serotypes (O5:H−, O91:H−, O128:H2, O146:H8, and O146:H21) have been the most frequently and the most commonly found in the sheep populations of different countries (2, 13, 20, 21). Numerous ovine STEC serotypes were associated with disease in humans. Thus, 55 (52%) of the 105 ovine serotypes have been also recovered from humans, including 24 serotypes associated with HUS (6, 23). Furthermore, 10 of the 12 most prevalent STEC serotypes in sheep in Spain were also found among STEC strains that cause human infections, including 5 serotypes (O5:H−, O91:H−, O128:H−, O128:H2, and O146:H8) associated with HUS (Table 2). Although our results and those of other authors indicate that STEC strains of human and animal origin with the same serotype are similar regarding the presence of known virulence-associated factors, future studies are necessary to establish if animal and human strains represent the same clones or are only related subpopulations (2, 3, 6, 10, 13, 22). Thus, the results of Boerlin et al. (10) suggest that STEC isolates from humans form a population different from those found in the bovine reservoir or that they are only a subpopulation of the latter.
Examination of non-O157 STEC serotypes from cattle and sheep revealed remarkable differences, which could point out an animal-host serotype specificity for some serotypes. Thus, 8 of the 21 non-O157 STEC serotypes more frequently detected in ovine strains in Spain (serotypes O52:H45, O91:H−, O104:H7, O110:H−, O112:H−, O123:H−, O128:H2, and O136:H20) are not included among the 323 non-O157 STEC serotypes detected in cattle to date (http://www.lugo.usc/ecoli) (6, 23). More than half (54%) of bovine non-O157 STEC strains have only the stx2 gene, whereas only 1% of strains of ovine origin have only the stx2 gene. Furthermore, the eae gene was detected in significantly fewer ovine non-O157 STEC (5%) than in bovine (17%) and human strains (45%) (6, 23).
The eae gene, which has been shown to be necessary for attaching-and-effacing activity, encodes a 94- to 97-kDa outer membrane protein termed intimin. Analysis of the nucleotide sequences of the intimin genes from different STEC and enteropathogenic E. coli strains has shown that a high degree of homology exists in the 5′ two-thirds of the genes and that a significant degree of heterogeneity exists in the 3′ one-third of the genes. Eight variants of the eae gene were identified by intimin type-specific PCR assays that used oligonucleotide primers complementary to the 3′ ends of the specific intimin genes that encode intimin types α, β1, β2, γ1, γ2, δ, ɛ, and ζ (1, 23, 24, 30, 33). In the present study, the new intimin, intimin type ζ, was detected in 15 (65%) of 23 ovine STEC strains which possessed the eae gene. In contrast, we found intimin type ζ in only 8 (13%) of 63 human STEC strains with the eae gene and 8 (5%) of 149 bovine STEC strains with the eae gene. We observed that intimin type ζ is especially associated with serotype O156:H−. Thus, of 31 STEC strains that possessed intimin type ζ, 17 (12 ovine strains, 4 bovine strains, and 1 human strain) belonged to serotype O156:H− (23). As in previous studies, all ovine STEC O157:H7 strains possessed intimin type γ1. Intimin types β1 (mainly associated with serotype O26:H11) and γ1 are the most frequently found in both human and bovine STEC strains.
Numerous investigators have underlined the strong association between carriage of the eae gene and the capacity of STEC strains to cause severe human disease, especially HUS. As this important virulence gene is present in only a minimal (5%) proportion of ovine non-O157 STEC strains, some of these ovine strains probably have low levels of virulence for humans. Nevertheless, production of intimin is not essential for pathogenesis, because a number of sporadic cases of HUS have been caused by eae-negative non-O157 STEC strains. Thus, STEC O104:H21 and O113:H21 strains lacking the eae gene were responsible for an outbreak and a cluster of three HUS cases in the United States and Australia, respectively (25). Furthermore, Paton and Paton (26) recently described a novel megaplasmid-encoded adhesin (Saa) which we have detected in most STEC strains lacking the eae gene (unpublished data). This adhesin may be an important virulence factor of eae-negative STEC strains capable of causing severe disease in humans.
O146:H25Total no.stx1stx2+ (β1)ehxAO126:H81++−+ O128:H−1++−+ O128:H−33++−− O128:H−1+−−+ O128:H−11+−−− O128:H23++−+ O128:H27++−− O128:H24+−−− O128:H81++−− O128:H101++−− O128:H211++−+ O136:H−1+−−− O136:H2011+−−− O146:H−1++−+ O146:H−1++−−O146:H814+−−− O146:H2114++−+ O146:H213++−− O146:H212+−−+ O146:H216+−−− O146:H212−+−+ O156:H−11+−+ (ζ)+ O156:H−1+−+ (ζ)− O156:H−1+−−+ O156:H111+−+ (β1)+ O156:H251+−+ (ζ)+ O156:H251+−−− O157:H75−++ (γ1)+ O166:H−2+−−+ O166:H285++−+ O166:H284+−−+ O166:H281+−−− O166:H281+−−+ O174:H211++−+ OX176:H−1+−−+ OX176:H46+−−+ OX176:H43+−−− OX177:H111+++ (β1)+ ONT:H−3++−+ ONT:H−1++−− ONT:H−1+−−+ ONT:H−4+−−− ONT:H42+−−− ONT:H161+−−− ONT:H211++−− ONT:H2116+−−− ONT:H291++−−
Acknowledgments
This study was supported by grants from the European Commission (FAIR Program grants CT98-3935 and CT98-4093), the Fondo de Investigación Sanitaria (grants FIS 98/1158 and FIS G03-025-COLIRED-O157), the Comisión Interministerial de Ciencia y Tecnología (grants CICYT-ALI98-0616 and CICYT-FEDER-1FD1997-2181-C02-01), and the Xunta de Galicia (grants XUGA 26105B97, XUGA 26106B97, and PGIDIT02BTF26101PR). A. Mora and G. Dahbi acknowledge the Xunta de Galicia and the Agencia Española de Cooperación Internacional for research fellowships.
REFERENCES
- 1.Adu-Bobie, J., G. Frankel, C. Bain, A. G. Goncalves, L. R. Trabulsi, G. Douce, S. Knutton, and G. Dougan. 1998. Detection of intimins α, β, γ, and δ, four intimin derivatives expressed by attaching and effacing microbial pathogens. J. Clin. Microbiol. 36:662-668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Beutin, L., D. Geier, H. Steinrück, S. Zimmermann, and F. Scheutz. 1993. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J. Clin. Microbiol. 31:2483-2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Beutin, L., D. Geier, S. Zimmermann, S. Aleksic, H. A. Gillespie, and T. S. Whittam. 1997. Epidemiological relatedness and clonal types of natural populations of Escherichia coli strains producing Shiga toxins in separate populations of cattle and sheep. Appl. Environ. Microbiol. 63:2175-2180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Beutin, L. 1999. Escherichia coli O157 and other types of verocytotoxigenic E. coli (VTEC) isolated from humans, animals and food in Germany, p. 121-145. In C. S. Stewart and H. J. Flint (ed.), Escherichia coli O157 in farm animals. CABI Publishing, Wallingford, United Kingdom.
- 5.Bielaszewska, M., J. Janda, K. Bláhová, H. Minaríková, E. Jíková, M. A. Karmali, J. Laubová, J. Sikulová, M. A. Preston, R. Khakhria, H. Karch, H. Klazarová, and O. Nyc. 1997. Human Escherichia coli O157:H7 infection associated with the consumption of unpasteurized goat's milk. Epidemiol. Infect. 119:299-305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Blanco, J., M. Blanco, J. E. Blanco, A. Mora, M. P. Alonso, E. A. González, and M. I. Bernárdez. 2001. Epidemiology of verocytotoxigenic Escherichia coli (VTEC) in ruminants, p. 113-148. In G. Duffy, P. Garvey, and D. McDowell (ed.), Verocytotoxigenic Escherichia coli. Food and Nutrition Press Inc., Trumbull, Conn.
- 7.Blanco, M., J. Blanco, J. E. Blanco, and J. Ramos. 1993. Enterotoxigenic, verotoxigenic and necrotoxigenic Escherichia coli isolated from cattle in Spain. Am. J. Vet. Res. 54:1446-1451. [PubMed] [Google Scholar]
- 8.Blanco, M., J. E. Blanco, J. Blanco, E. A. González, A. Mora, C. Prado, L. Fernández, M. Rio, J. Ramos, and M. P. Alonso. 1996. Prevalence and characteristics of Escherichia coli serotype O157:H7 and other verotoxin-producing E. coli in healthy cattle. Epidemiol. Infect. 117:251-257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Blanco, M., J. E. Blanco, E. A. González, A. Mora, W. Jansen, T. A. T. Gomes, F. Zerbini, T. Yano, A. F. Pestana de Castro, and J. Blanco. 1997. Genes coding for enterotoxins and verotoxins in porcine Escherichia coli strains belonging to different O:K:H serotypes: relationship with toxic phenotypes. J. Clin. Microbiol. 35:2958-2963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Boerlin, P., S. A. McEwen, F. Boerlin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chapman, P. A., C. A. Siddons, A. T. Cerdan Malo, and M. A. Harkin. 1997. A 1-year study of Escherichia coli O157 in cattle, sheep, pigs and poultry. Epidemiol. Infect. 119:245-250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chapman, P. A., A. T. Cerdán Malo, M. Ellin, R. Ashton, and M. A. Harkin. 2001. Escherichia coli O157 in cattle and sheep at slaughter, on beef and lamb carcasses and in raw beef and lamb products in South Yorkshire, UK. Int. J. Food Microbiol. 64:139-150. [DOI] [PubMed] [Google Scholar]
- 13.Djordjevic, S. P., M. A. Hornitzky, G. Bailey, P. Gill, B. Vanselow, K. Walker, and K. A. Bettelheim. 2001. Virulence properties and serotypes of Shiga toxin-producing Escherichia coli from healthy Australian slaughter-age sheep. J. Clin. Microbiol. 39:2017-2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fagan, P. K., M. A. Hornitzky, K. A. Bettelheim, and S. P. Djordjevic. 1999. Detection of Shiga-like toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR. Appl. Environ. Microbiol. 65:868-872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Guinée, P. A. M., W. H. Jansen, T. Wadström, and R. Sellwood. 1981. Escherichia coli associated with neonatal diarrhoea in piglets and calves. Curr. Top. Vet. Anim. Sci. 13:126-162. [Google Scholar]
- 16.Heuvelink, A. E., F. L. A. M. Van Den Biggelaar, E. De Boer, R. G. Herbes, W. J. G. Melchers, J. H. J. Huis In′T Veld, and L. A. H. Monnens. 1998. Isolation and characterization of verocytotoxin-producing Escherichia coli O157 strains from Dutch cattle and sheep. J. Clin. Microbiol. 36:878-882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jerse, A. E., J. Yu, B. D. Tall, and J. B. Kaper. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. USA 87:7839-7843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Johnsen, G., Y. Wasteson, E. Heir, O. I. Berget, and H. Herikstad. 2001. Escherichia coli O157:H7 in faeces from cattle, sheep and pigs in the southwest part of Norway during 1998 and 1999. Int. J. Food Microbiol. 65:193-200. [DOI] [PubMed] [Google Scholar]
- 19.Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:5-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kudva, I. T., P. G. Hatfield, and C. J. Hovde. 1996. Escherichia coli O157:H7 in microbial flora of sheep. J. Clin. Microbiol. 34:431-433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kudva, I. T., P. G. Hatfield, and C. J. Hovde. 1997. Characterization of Escherichia coli O157:H7 and other Shiga toxin-producing E. coli serotypes isolated from sheep. J. Clin. Microbiol. 35:892-899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Meng, J., S. Zhao, and M. P. Doyle. 1998. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans. Int. J. Food Microbiol. 45:229-235. [DOI] [PubMed] [Google Scholar]
- 23.Mora, A. 2002. Escherichia coli verotoxigénicos (ECVT) O157:H7 y no O157. Prevalencia, serotipos, fagotipos, genes de virulencia, tipos de intiminas, perfiles de PFGE y resistencia a antibióticos de ECVT de origen humano y animal. Doctoral thesis. Universidad de Santiago de Compostela, Lugo, Spain.
- 24.Oswald, E., H. Schmidt, S. Morabito, H. Karch, O. Marchès, and A. Caprioli. 2000. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68:64-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Paton, A. W., M. C. Woodrow, R. M. Doyle, J. A. Lanser, and J. C. Paton. 1999. Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J. Clin. Microbiol. 37:3357-3361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Paton, A. W., and J. C. Paton. 2002. Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J. Clin. Microbiol. 40:271-274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Schmidt, H., L. Beutin, and H. Karch. 1995. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sidjabat-Tambunan, H., and J. C. Bensink. 1997. Verotoxin-producing Escherichia coli from the faeces of sheep, calves and pigs. Aust. Vet. J. 75:292-293. [DOI] [PubMed] [Google Scholar]
- 30.Son, W. G., T. A. Graham, and V. P. J. Gannon. 2002. Immunological characterization of Escherichia coli O157:H7 intimin γ1. Clin. Diagn. Lab. Immunol. 9:46-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tarr, C. L., and S. Whittam. 2002. Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J. Bacteriol. 184:479-487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Urdahl, A. M., O. Alvseike, E. Skjerve, and Y. Wasteson. 2001. Shiga toxin genes (stx) in Norwegian sheep herds. Epidemiol. Infect. 127:129-134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Wieler, L. H., E. Vieler, C. Erpenstein, T. Schlapp, H. Steinrück, R. Bauerfeind, A. Byomi, and G. Baljer. 1996. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J. Clin. Microbiol. 34:2980-2984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zschöck, M., H. P. Hamann, B. Kloppert, and W. Wolter. 2000. Shiga-toxin-producing Escherichia coli in faeces of healthy dairy cows, sheep and goats: prevalence and virulence properties. Lett. Appl. Microbiol. 31:203-208. [DOI] [PubMed] [Google Scholar]